Boehringer Ingelheim Vetmedica, Inc.

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Boehringer_Ingelheim_Animal_Health
gptkb:Vetoquinol
Merial
gptkbp:awards Industry awards
Sustainability awards
Innovation awards
gptkbp:communityInvolvement Local charities
Educational initiatives
Veterinary outreach programs
gptkbp:conference Veterinary conferences
Research conferences
Animal health symposiums
gptkbp:employees Over 1,000
gptkbp:established 2000
gptkbp:financials Market share
Revenue in billions
Investment in R&D
Annual growth rate
gptkbp:focus Veterinary medicine
gptkbp:foundedBy gptkb:Boehringer_Ingelheim
gptkbp:futurePlans New product development
Expansion in emerging markets
Increased investment in technology
gptkbp:globalPresence gptkb:Asia
gptkb:Latin_America
gptkb:North_America
Africa
Europe
gptkbp:headquarters gptkb:St._Joseph,_Missouri,_USA
https://www.w3.org/2000/01/rdf-schema#label Boehringer Ingelheim Vetmedica, Inc.
gptkbp:industry Pharmaceuticals
gptkbp:market Global
gptkbp:parentCompany gptkb:Boehringer_Ingelheim
gptkbp:partnerships Research institutions
Veterinary schools
Animal health organizations
gptkbp:products Antibiotics
Vaccines
Parasiticides
gptkbp:researchFocus Diagnostics
Therapeutics
Vaccination technology
gptkbp:specializesIn Animal health
gptkbp:subsidiary gptkb:Boehringer_Ingelheim
gptkbp:sustainabilityInitiatives Community engagement
Animal welfare
Environmental responsibility
gptkbp:website www.boehringer-ingelheim.com